Alvotech(ALVOW)
LUXEMBOURG, Luxembourg
BiotechnologyFocus: Biosimilars
Alvotech is a life sciences company focused on Biosimilars.
ImmunologyNeurologyGastroenterologyOphthalmology
Funding Stage
PUBLIC
Open Jobs
43
Products & Portfolio (2)
Pipeline & Clinical Trials
Stelara PFS
PsoriasisClinical Trials (1)
NCT04744363Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)
Phase 1Adalimumab
Phase 1Clinical Trials (1)
NCT03983876PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)
Phase 1Clinical Trials (1)
NCT05876949AVT03 With Xgeva in Healthy Male Subjects
Phase 1Adalimumab
Healthy VolunteersClinical Trials (1)
NCT03849313Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)
Phase 1AVT16
HealthyClinical Trials (1)
NCT06400719Pilot Study of AVT16 in Healthy Adult Subjects
Phase 1Adalimumab 100 MG/ML [Humira]
Healthy VolunteersClinical Trials (1)
NCT03579823Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers
Phase 1Phase 1
Clinical Trials (1)
NCT05126784AVT03 With Prolia in Healthy Male Subjects
Phase 1Phase 1
Clinical Trials (1)
NCT06732804Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio
Phase 1Phase 1
Clinical Trials (1)
NCT05632211A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants
Phase 1Adalimumab originator
Plaque PsoriasisClinical Trials (1)
NCT04453137Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis
Phase 3Adalimumab
Plaque PsoriasisClinical Trials (1)
NCT03849404Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis
Phase 3Stelara
PsoriasisClinical Trials (1)
NCT04930042Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis
Phase 3AVT05
Rheumatoid ArthritisClinical Trials (1)
NCT05842213Comparative, Multicenter Study in Subjects with Rheumatoid Arthritis, ALVOFLEX
Phase 3Patients will receive 1 IVT injection of AVT06 PFS depending on their chorioretinal vascular disease schedule
Chorioretinal Vascular DiseaseClinical Trials (1)
NCT05986786Clinical Study to Evaluate the Handling and Safety of AVT06 PFS in Subjects With Chorioretinal Vascular Disease
Phase 3Phase 3
Clinical Trials (1)
NCT05155293Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE)
Phase 3Adalimumab
RAClinical Trials (1)
NCT04224194Auto-injector Real Life Handling in Patients
Phase 3Phase 3
Clinical Trials (1)
NCT05395091Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND
Phase 3AVT16
Ulcerative ColitisClinical Trials (1)
NCT06570772Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio
Phase 3Open Jobs (43)
Medical Writer
Bangalore Office
23h ago
Scientist, Analytical R&D
Reykjavik Headquarters
23h ago
Pharmacovigilance Manager, Benefit Risk management
Bangalore Office
23h ago
Clinical Data Management Specialist
Bangalore Office
23h ago
Pharmacovigilance Specialist, Safety data management
Bangalore Office
23h ago
Director, Clinical Quality Evaluation and Inspection Intelligence
Stockholm Office
23h ago
Reliability Engineer
Reykjavik Headquarters
23h ago
Senior Scientist, ARD Potency and Binding
Reykjavik Headquarters
23h ago
Principal Specialist Bioanalytical Study Quality
Stockholm Office
23h ago
Scientist in Potency and Binding
Reykjavik Headquarters
23h ago
Principal Specialist Pharmacovigilance Quality
Bangalore Office
23h ago
Pharmacovigilance Specialist, Safety data management
Bangalore Office
23h ago
Pharmacovigilance associate, Safety data management
Bangalore Office
23h ago
Senior Pharmacovigilance Specialist, Safety Data Management
Bangalore Office
23h ago
Director, Benefit Risk Management
Stockholm Office
Yesterday
Principal Scientist - Forced Degradation
Bangalore Office
Yesterday
Maintenance Planner
Reykjavik Headquarters
Yesterday
Director, Clinical trials and Partner Compliance
Stockholm Office
Yesterday
Pharmacovigilance Manager, Benefit Risk management
Stockholm Office
Yesterday
Expert Scientist – New Product Introduction
Reykjavik Headquarters
5d ago
Senior Pharmacovigilance Specialist, Safety Data Management
Bangalore Office
6d ago
Senior Administrative Specialist - BioAnalytics
Stockholm Office
6d ago
Scientific Director - BioAnalytics
Stockholm Office
6d ago
Director, Safety Data Management
Stockholm Office
6d ago
Laboratory Specialist Bioanalytics
Stockholm Office
6d ago
Interview Prep Quick Facts
Portfolio: 2 approved products, 18 clinical trials
Top TAs: Immunology, Ophthalmology
Open Roles: 43 active jobs
Portfolio Health
Growth2 (100%)
2 total products
Hiring Trend
Actively Hiring
43
Open Roles
+35
Added
-7
Filled/Removed
Based on last 4 crawl cycles